Free Trial

Promising Medical Stocks To Watch Today - August 17th

UnitedHealth Group logo with Medical background

Key Points

  • UnitedHealth Group, Eli Lilly, and Johnson & Johnson are highlighted as key medical stocks to monitor today due to their high trading volume.
  • UnitedHealth Group's stock traded at $304.02 with a market cap of $275.34 billion, while Eli Lilly surged to $701.51, reflecting a market cap of $663.95 billion.
  • Johnson & Johnson, trading at $176.76, has a diverse operation in healthcare including Innovative Medicine and MedTech segments, focusing on various diseases and medical technologies.
  • Looking to export and analyze UnitedHealth Group data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

UnitedHealth Group, Eli Lilly and Company, and Johnson & Johnson are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies operating in the healthcare sector—this includes pharmaceutical and biotechnology firms, medical device manufacturers, hospitals and other care providers. Investing in these stocks lets shareholders participate in the development, approval and distribution of medical treatments, technologies and services. Their performance is often driven by factors such as clinical trial results, regulatory decisions and broader healthcare policy changes. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

NYSE:UNH traded up $32.53 during trading hours on Friday, hitting $304.02. 67,934,484 shares of the company's stock traded hands, compared to its average volume of 19,286,994. The firm has a market cap of $275.34 billion, a P/E ratio of 13.17, a P/E/G ratio of 1.96 and a beta of 0.43. UnitedHealth Group has a 52 week low of $234.60 and a 52 week high of $630.73. The business's fifty day simple moving average is $288.91 and its two-hundred day simple moving average is $396.85. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

Read Our Latest Research Report on UNH

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE:LLY traded up $17.08 during trading hours on Friday, hitting $701.51. 8,211,278 shares of the company's stock traded hands, compared to its average volume of 6,346,453. The firm has a market cap of $663.95 billion, a P/E ratio of 45.85, a P/E/G ratio of 0.98 and a beta of 0.44. Eli Lilly and Company has a 52 week low of $623.78 and a 52 week high of $972.53. The business's fifty day simple moving average is $764.55 and its two-hundred day simple moving average is $794.63. The company has a quick ratio of 1.00, a current ratio of 1.28 and a debt-to-equity ratio of 1.86.

Read Our Latest Research Report on LLY

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

NYSE:JNJ traded up $2.04 during trading hours on Friday, hitting $176.76. 9,476,237 shares of the company's stock traded hands, compared to its average volume of 8,427,234. The firm has a market cap of $425.70 billion, a P/E ratio of 18.90, a P/E/G ratio of 2.25 and a beta of 0.41. Johnson & Johnson has a 52 week low of $140.68 and a 52 week high of $177.27. The business's fifty day simple moving average is $161.28 and its two-hundred day simple moving average is $158.39. The company has a quick ratio of 0.76, a current ratio of 1.01 and a debt-to-equity ratio of 0.50.

Read Our Latest Research Report on JNJ

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines